Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
ViroPharma Inc. (VPHM)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: VPHM
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Wall Street Breakfast: Must-Know News
Apr 29
•
SA Editor Rachael Granby
•
AAPL
,
ACE
,
AET
•
30 Comments
Wall Street Breakfast: Must-Know News
Feb 24
•
SA Editor Rachael Granby
•
AIG
,
AXP
,
BAC
•
13 Comments
Buying ViroPharma Ahead of June 3rd FDA Decision
May 28
•
Mark Cifra
•
VPHM
•
12 Comments
ViroPharma: Lev Acquisition Appraisal
Aug 3, 2008
•
Value Geek
•
LEVP.OB
,
VPHM
•
10 Comments
9 Possible Pharma Deals for 2009
Jan 8
•
Zacks.com
•
ACOR
,
AMGN
,
ARNA
•
7 Comments
Watch for More Coming Biotech Acquisitions
Aug 3, 2008
•
Zacks.com
•
BMY
,
BRL
,
DNA
•
7 Comments
Biotech Update: Arena Pharmaceuticals, Acusphere, Cephalon, ViroPharma, Auxilium
Nov 3, 2008
•
Zacks.com
•
ACUS
,
ARNA
,
AUXL
•
6 Comments
Top 10 Dividend, P/S and P/B Ratio Stocks
Apr 28
•
Steve Alexander
•
AHCI
,
CHKE
,
DELL
•
5 Comments
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Apr 2
•
Mark Cifra
•
ACOR
,
ARNA
,
CVTX
•
5 Comments
Jim Cramer's Mad Money Lightning Round 10/2/07: Bucyrus Comes Back
Oct 3, 2007
•
SA Editor Miriam Metzinger
•
AAPL
,
AGU
,
BIDU
•
4 Comments
Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals
Oct 12, 2008
•
Dan Weiss
•
LEVP.OB
,
VPHM
•
3 Comments
Analysts Even More Bullish on ViroPharma
Dec 4, 2008
•
Zacks.com
•
VPHM
•
3 Comments
Forecast for ViroPharma's Pipeline: Mostly Shiny
Jan 14, 2008
•
Brett Scott
•
VPHM
•
3 Comments
Maribavir Should Guide Viropharma Higher
Mar 11, 2008
•
Tony Kent
•
VPHM
•
3 Comments
Contrarian Stock Screen: Biggest Losers in 2009
Jul 12
•
The Manual of Ideas
•
BEAT
,
BLUD
,
CPD
•
3 Comments
Stocks with the Smallest PEG Ratios
Nov 5, 2007
•
TickerSense
•
ABK
,
ATW
,
CETV
•
2 Comments
Friday Options Recap
May 29
•
Frederic Ruffy
•
BEAT
,
DELL
,
ELN
•
2 Comments
Is ViroPharma a Buy Despite Seemingly Weak Fundamentals?
Mar 13, 2008
•
Donald Johnson
•
VPHM
•
2 Comments
Monday's Options Recap
Mar 23
•
Frederic Ruffy
•
AMD
,
BAC
,
C
•
2 Comments
Biotech Names With Big Potential
Sep 23, 2008
•
Zacks.com
•
ABT
,
DNA
,
GENZ
•
2 Comments
Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair
Oct 9, 2008
•
Dan Weiss
•
LEVP.OB
,
VPHM
•
2 Comments
ViroPharma Incorporated: Value in a Pharmaceutical
Nov 12, 2007
•
Value Geek
•
VPHM
•
1 Comment
2008 Stock Market: 51 Rays of Light
Jan 7
•
Market Folly
•
AAN
,
ALGT
,
ALO
•
1 Comment
ViroPharma Incorporated: More FDA Incompetence
Jan 18, 2008
•
Theodore Cohen
•
VPHM
•
1 Comment
2009: Positive Outlook for Biotech
Jan 8
•
Michael Becker
•
AMGN
,
ARQL
,
CBST
•
1 Comment
ViroPharma: FDA Issues Complete Response Letter for Cinryze
Jun 4
•
Zacks.com
•
VPHM
•
1 Comment
Smaller Pharma Wins the 'Most Valuable' Race
Jul 1
•
EP Vantage
•
ALKS
,
AMGN
,
CELG
•
1 Comment
Viropharma: Failed Bet on Orphan Drug
Feb 10
•
Donald Johnson
•
VPHM
•
1 Comment
Does More Cash and Less Debt Equal Stock Market Gains?
Apr 23
•
Trade Radar Operator
•
ADPT
,
AIRV
,
BBND
•
1 Comment